Randomized phase II study of cisplatin/vinorelbine vs cisplatin/gemcitabine vs vinorelbine/gemcitabine in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Tsai, CM [1 ]
Perng, RP [1 ]
Wang, GS [1 ]
Chen, YM [1 ]
机构：
[1] Taipei Vet Gen Hosp, Chest Dept, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [21] Cisplatin, gemcitabine, vinorelbine (PGV) vs cisplatin and gemcitabine (PG) vs cisplatin, gemcitabine, paclitaxel (PGT) in advanced NSCLC:: Final analysis a phase III trial
    Comella, G
    Frasci, G
    Panza, N
    Nicolella, G
    Manzione, I
    De Cataldis, G
    Cioffi, R
    Micillo, E
    Lorusso, V
    Bilancia, D
    Maiorino, L
    Piantedosi, FV
    Mangiameli, A
    Gravina, A
    Lamberti, A
    De Lena, M
    Comella, P
    ANNALS OF ONCOLOGY, 2000, 11 : 3 - 3
  • [22] Gemcitabine and vinorelbine in advanced non-small cell lung cancer
    Vazquez, F
    Cueva, JF
    Baron, FJ
    Candamio, S
    Calvo, M
    Irigoyen, A
    Huidobro, C
    Lopez, R
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [23] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169
  • [24] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    Javier Castro de Carpeño
    M. González Barón
    J. Aguiar
    J. I. Chacón
    J. Feliu
    M. J. García
    C. Madroñal
    A. Colmenarejo
    J. J. Sánchez
    A. Ordóñez
    Cancer Chemotherapy and Pharmacology, 2006, 58
  • [25] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    de Carpeño, JC
    Barón, MG
    Aguiar, J
    Chacón, JI
    Feliu, J
    García, MJ
    Madroñal, C
    Colmenarejo, A
    Sánchez, JJ
    Ordóñez, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 266 - 271
  • [26] A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
    Blackhall, Fiona H.
    O'Brien, Mary
    Schmid, Peter
    Nicolson, Marianne
    Taylor, Paul
    Milenkova, Tsveta
    Kennedy, Sarah J.
    Thatcher, Nick
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1285 - 1288
  • [27] Randomized study of vinorelbine-gemcitabine versus vinorelbine-carboplatin in patients with advanced non-small cell lung cancer
    Tan, EH
    Szczesna, A
    Krzakowski, M
    Macha, HN
    Gatzemeier, U
    Mattson, K
    Wernli, M
    Reiterer, P
    Hui, R
    Von Pawel, J
    Bertetto, O
    Pouget, JC
    Burillon, JP
    Parlier, Y
    Abratt, R
    LUNG CANCER, 2005, 49 (02) : 233 - 240
  • [28] Multicenter phase II study of gemcitabine, vinorelbine and ifosfamide in advanced non-small cell lung cancer
    Recchia, F
    Lombardo, M
    De Filippis, S
    Russelli, M
    Saggio, G
    Piccinini, M
    Rea, S
    ANNALS OF ONCOLOGY, 2000, 11 : 10 - 10
  • [29] Cisplatin, gemcitabine and vinorelbine in locally advanced or metastatic non-small-cell lung cancer: A phase I study
    Frasci, G
    Panza, N
    Comella, P
    Nicolella, GP
    Natale, M
    Pacilio, C
    Gravina, A
    Caputi, V
    Botti, G
    Comella, G
    ANNALS OF ONCOLOGY, 1997, 8 (10) : 1045 - 1048
  • [30] Randomized trial comparing cisplatin, gemcitabine, and vinorelbine with either cisplatin and gemcitabine or cisplatin and vinorelbine in advanced non-small-cell lung cancer: Interim analysis of a phase III trial of the southern Italy Cooperative Oncology Group
    Comella, P
    Frasci, G
    Panza, N
    Manzione, L
    De Cataldis, G
    Cioffi, R
    Maiorino, L
    Micillo, E
    Lorusso, V
    Di Rienzo, G
    Filippelli, G
    Lamberti, A
    Natale, M
    Bilancia, D
    Nicolella, G
    Di Nota, A
    Comella, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) : 1451 - 1457
12345